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The ocular motility disorder ‘‘Congenital fibrosis of
the extraocular muscles type 1’’ (CFEOM1) results
from heterozygous mutations altering the motor
and third coiled-coil stalk of the anterograde kinesin,
KIF21A. We demonstrate that Kif21a knockin mice
harboring the most common human mutation
develop CFEOM. The developing axons of the oculo-
motor nerve’s superior division stall in the proximal
nerve; the growth cones enlarge, extend excessive
filopodia, and assume random trajectories. Inferior
division axons reach the orbit but branch ectopically.
We establish a gain-of-function mechanism and find
that human motor or stalk mutations attenuate
Kif21a autoinhibition, providing in vivo evidence for
mammalian kinesin autoregulation. We identify
Map1b as a Kif21a-interacting protein and report
thatMap1b/mice develop CFEOM. The interaction
between Kif21a and Map1b is likely to play a critical
role in the pathogenesis of CFEOM1 and highlights334 Neuron 82, 334–349, April 16, 2014 ª2014 Elsevier Inc.a selective vulnerability of the developing oculomo-
tor nerve to perturbations of the axon cytoskeleton.
INTRODUCTION
A subset of the 45 human kinesin motor proteins contributes to
neuronal development and maintenance through cargo trans-
portation and/or cytoskeletal regulation, and mutations in eight
kinesins have been reported to cause neurological disorders.
Among these, congenital fibrosis of the extraocular muscles
type 1 (CFEOM1) results from a small number of recurrent and
often de novo heterozygous mutations in the kinesin-4 family
member, KIF21A (Yamada et al., 2003). CFEOM1 is a disorder
limited to congenital blepharoptosis (ptosis or drooping eyelids)
and restricted eye movements. Vertical movements are mark-
edly limited and neither eye can be elevated above the midline,
while horizontal movements vary from full to none. Aberrant
residual eyemovements are common, supporting errors in extra-
ocular muscle (EOM) innervation (Engle et al., 1997; Yamada
et al., 2003).
KIF21A is composed of an amino terminal motor domain, a
central stalk domain, and a carboxy terminal domain containing
Figure 1. Kif21a R954W KI Mice Recapitu-
late Human CFEOM1
(A) Schematic of KIF21A protein highlighting
amino acid substitutions (red) and single residue
deletion (purple) resulting from human CFEOM1
mutations. The number of reported unrelated
probands is indicated within parentheses if there
is more than one.
(B) Alignment of human and mouse KIF21A
demonstrates conservation of the motor domain
(MT1) and two third coiled-coil stalk domain (MT2
and MT3) substitutions studied.
(C) 129/S1 Kif21a+/+ mouse with normal eyes.
(D and E) 129/S1 Kif21aKI/KI mice with bilateral (D)
and unilateral (E) ptosis and globe retraction.
(F) Penetrance of eye phenotype in adultKif21a+/KI
and Kif21aKI/KI mice.
(G) Bilateral motor neuron cell counts of adult
Kif21a+/+ versus Kif21aKI/KImice: OMN 1,023 ± 31
versus 612 ± 54; abducens 137 ± 6 versus 113 ± 5;
facial 1,628 ± 75 versus 1,579 ± 40; trochlear
249 ± 25 versus 239 ± 22; n = 4, 4 **p < 0.001,
***p < 0.0001. Mean ± SD.
(H–K) H&E-stained cross-sections of EOMs pos-
terior to the globe from adult Kif21a+/+ (H and J)
and Kif21aKI/KI (I and K) mice, with LPS and SR at
higher magnification in (J) and (K) (n = 6, 6). LSP
indicated by arrow. Scale bars represent 200 mm
in (H) and (I) and 50 mm in (J) and (K).
(L–Q) Confocal images of isolated EOM innerva-
tion after anterograde lipophilic dye tracer studies
of ocular cranial nerves in P0 Kif21a+/+ (L–N) and
Kif21aKI/KI (O–Q) mice. Note decreased innerva-
tion received by LPS (L and O), SR (M and P), and
LR (N and Q) in Kif21aKI/KI compared to Kif21a+/+
mice (n = 5, 5). Dashed lines outline boundary of
muscle bodies oriented from origin (top) to inser-
tion (bottom). Scale bars represent 100 mm.
Abbreviations: ON, optic nerve; LPS, levator pal-
pebrae superioris; SR, superior rectus; LR, lateral
rectus; MR, medial rectus; IR, inferior rectus.
See also Figure S1.
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zygous single amino acid deletion account for all KIF21A muta-
tions among the 106 unrelated CFEOM1 probands reported
to date (Chan et al., 2007; Lu et al., 2008; Wang et al., 2011).
The mutations alter six amino acid residues in the third coiled-
coil region of the stalk and two residues in the motor domain
and result in indistinguishable phenotypes that are limited to
ptosis and ocular dysmotility (Demer et al., 2005; Yamada
et al., 2003). Mapping the mutations to the Kif21a primary and
the three-dimensional motor structures highlight the clustering
of 11 mutations in the third coiled-coil stalk domain, while two
mutations map close to one another in loop 1 and helix a6 on
the lateral surface of the highly conserved motor domain, a
region of unknown function far from the kinesin motor nucleo-
tide-binding pocket and the microtubule-binding domain (Fig-
ures 1A and S1A available online).
Kif21a is an anterograde ATP-dependent motor protein (Mars-
zalek et al., 1999) that interacts in vitro with Kank1, a regulator of
actin polymerization (Kakinuma and Kiyama, 2009). The interac-tion of Kif21a with the Kank1/LL5B complex at the cell cortex
stabilizes microtubule dynamics in vitro (van der Vaart et al.,
2013). Human and mouse KIF21A/Kif21a is expressed widely
in vivo and is present in the cell body, axons, and dendrites of
most neuronal populations including cranial motor neurons, as
well as in EOM and skeletal muscles, from early development
into adulthood (Desai et al., 2012). The spatial expression of
KIF21A does not appear altered in individuals with CFEOM1
(Desai et al., 2012). Thus, the neurobiology of CFEOM1 and
how human Kif21a mutations cause this very circumscribed
developmental disorder remain unclear.
In this study, we generated Kif21a knockin and knockout
mouse models to define the CFEOM1 disease etiology, and
demonstrate that CFEOM1 mutations act through a gain-of-
function mechanism to attenuate Kif21a autoinhibition. We find
that mutant hyperactive Kif21a causes thinning of the distal
oculomotor (OMN) nerve with hypoplasia of the superior division
(OMNsd) and aberrant branching of the inferior division (OMNid).
Stalled proximal OMNsd axons have turning defects, withNeuron 82, 334–349, April 16, 2014 ª2014 Elsevier Inc. 335
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KIF21A Function in CFEOM1 and Developmentenlarged growth cones and increased numbers of filopodia.
We then demonstrate that Kif21a interacts with Map1b and
Map1b/mice have CFEOM1, supporting a critical role of their
interaction in the pathogenesis of CFEOM1.
RESULTS
Kif21a R954W Knockin Mice Recapitulate Human
CFEOM1
Human KIF21A and mouse Kif21a proteins are 93% homo-
logous, and all residues altered by CFEOM1 mutations are
conserved between the two species (Figure 1B). Moreover,
74% of probands harbor the specific R954W substitution, while
89% harbor mutations that alter residue R954. Thus, to study the
pathogenesis of CFEOM1, we introduced a 2,827C/Tmutation
into the endogenous mouse Kif21a locus, generating Kif21a
knockin mice harboring R943W (Kif21aKI), the equivalent of the
human R954W substitution (Figures S1B–S1D). Kif21a+IKI and
Kif21aKI/KI mice are viable, fertile, and recovered in Mendelian
ratios, and two separately generated 129/S1 Kif21aKI lines
were indistinguishable. Adult 129/S1 Kif21aKI mice exhibit the
CFEOM1 external phenotype of unilateral or bilateral ptosis
and/or globe retraction that is 92% penetrant and primarily
bilateral in Kif21aKI/KI mice, 43% penetrant and primarily unilat-
eral in Kif21a+IKI mice, and absent in Kif21a+/+ mice (Figures
1C–1E and 1F).
EOMs are innervated by the paired OMN, trochlear, and abdu-
cens cranial nerves (Figure S1E). The OMN nerve divides just
prior to entering the orbit, with the larger OMNid innervating
the medial rectus (MR), inferior rectus (IR), and inferior oblique
(IO) muscles and the ciliary ganglion, and the smaller OMNsd
innervating the superior rectus (SR) and the levator palpebrae
superioris (LPS) muscles. Postmortem pathology of an adult
with CFEOM1 (Engle et al., 1997) resulting from the R954W
KIF21A amino acid substitution (Yamada et al., 2003) revealed
hypoplasia of the SR and LPS EOMs that elevate the eye and
eyelid, respectively, and absence of the OMNsd and corre-
sponding somatic motor neurons (Figure S1E). The OMNid and
the abducens nerve were also thin, and the EOMs they inner-
vated had nonspecific changes. Similar orbital changes were
documented by MRI of individuals with CFEOM1 and motor or
stalk mutations (Demer et al., 2005).
We asked whether mature Kif21aKI/KI mice recapitulated the
human CFEOM1 pathology. Bilaterally affected adult Kif21aKI/KI
mice had a 38% and 12% reduction in the number of OMN
and abducens motor neurons, respectively, compared to wild-
type (WT) mice (Figures 1G and S1F). The LPS muscle was
markedly reduced in size, with persistent attachment to the SR
(Figures 1H–1K). Moreover, LPS and SR EOM innervation and,
to a lesser degree, LR EOM innervation, were altered (Figures
1L–1Q). In contrast, innervation of other EOMs, ciliary ganglion,
nasal sensory pad, and efferent fibers to the cochlea were largely
indistinguishable between mutant and WT mice (Figures
S1G–S1L). General autopsy, overall brain and brainstem size
and architecture, and retinal ganglion cell axonal projections
appeared unremarkable (Figures S1M–S1S). Furthermore,
affected Kif21aKI/KI mice had normal behavioral visual acuity of
0.4 cycles/degree (Prusky et al., 2004). Thus, Kif21aKI/KI mice336 Neuron 82, 334–349, April 16, 2014 ª2014 Elsevier Inc.recapitulated findings observed in humans with CFEOM1 with
minimal differences. Unlike outbred but similar to some inbred
families (Sener et al., 2000; Yamada et al., 2004), the mice had
an incompletely penetrant CFEOM1 phenotype that varied with
genetic background, could appear unilateral, and generally had
only mild SR muscle pathology.
Kif21aKI/KI Oculomotor Nerve Superior Branch Axons
Terminate Prematurely within a Bulb
We evaluated peripheral nerve development in embryonic day
(E) 11.5 Kif21aKI/KI whole-mount embryos. To enhance visuali-
zation of developing motor nuclei and nerves, we crossed
Kif21aKI and WT mice to IslMN:GFP transgenic mice (Lewcock
et al., 2007). The exit, outgrowth, and trajectory of the OMN, as
well as other cranial and spinal nerves of Kif21aKI/KI embryos,
could not be distinguished from WT littermates (Figures 2A,
2B, S2A, and S2B). This is in contrast to the TUBB3KI/KI mutant
OMN nerve in a similar OMN disorder, CFEOM3, which projects
aberrantly toward the superior oblique muscle that is normally
innervated by the trochlear nerve (Tischfield et al., 2010). We
did, however, note thinning of distal OMN nerves in Kif21aKI/KI
embryos (Figures 2B and S2B).
We asked whether distal OMN nerve thinning in CFEOM1
resulted from errors in OMN neuron identity but did not detect
differences in molecular markers specific for their identity in
Kif21aKI/KI versus WT mice (Figures S2C and S2D). Moreover,
E10.5–E13.5 Kif21aKI fluorescent OMN and trochlear nuclei
and trochlear nerves were indistinguishable from WT (Figures
2C–2H). Although mutant OMN axons appeared to exit the
brainstem appropriately as multiple rootlets, at both E12.5 and
E13.5 the proximal mutant nerves appeared thicker than WT
(Figures 2E–2H).
To better visualize the developing nerve, we dissected and
imaged Kif21a+/+, Kif21+IKI, and Kif21aKI/KI mutant fluorescent
OMN nerves from E12.5 embryos (Figures 2I, 2J, and S2E).
We found that the nerve thickening ended within the first half
of the peripheral nerve trajectory as a single smooth, circum-
scribed enlargement that we refer to as the bulb. Distal to the
bulb, each mutant nerve was thin. Most Kif21aKI/KI mice devel-
oped bulbs bilaterally, while Kif21+/KImice typically had a thinner
distal nerve but only a 50% incidence of bulb formation, and
Kif21a+/+ mice had neither thinning nor bulbs. We stained fluo-
rescent OMN nerves with anti-neurofilament (NF) antibody to
better visualize single axons (Figures 2K–2N and S2F).Kif21aKI/KI
axons proximal to the bulb had straight trajectories similar to
WT. Within the bulb, a subset of axons pursued complex trajec-
tories and appeared to terminate, while others maintained
straight trajectories and exited the bulb to form the thin distal
nerve.
We employed ex vivo anterograde and retrograde tracer
studies to identify the axon population terminating within the
bulb (Figures S2G–S2N). The bulb was detected by anterograde
lipophilic dye labeling (Figures S2O and S2P), and we took
advantage of the normal contralateral innervation pattern of
the OMNsd to label OMNsd axons versus both OMNsd and
OMNid axons using two dye colors (Figures 2O–2T). Two-color
labeling revealed that the prematurely terminating axons were
primarily those of the OMNsd, which originated from the
Figure 2. Oculomotor Nerve Pathology in
Kif21aKI/KI Mice
(A and B) Whole-mount fluorescent immunostaining
with anti-NF (red) and anti-GFP (green) antibodies of
E11.5 Kif21a+/+;IslMN:GFP (A) and Kif21aKI/KI;IslMN:GFP
(B) embryos (n = 22, 20) reveal similar trajectories ofWT
andmutant cranial nerves. Arrowhead in (A) points to VI
nerve; arrow in (B) highlights distal thinning of III nerve
in the mutant compared to WT. Scale bar represents
200 mm.
(C–H) Images of dorsal view of flat-mounted midbrain
tissue from Kif21a+/+;IslMN:GFP (C, E, and G) and
Kif21aKI/KI;IslMN:GFP (D, F, and H) embryos at E10.5
(C and D), E12.5 (E and F), and E13.5 (G and H); n = 5, 5
for each age. Note the normal appearance of mutant III
and IV nuclei and exiting nerves. At E12.5 and E13.5,
mutant III nerve is thickened following exit into the
periphery compared toWT (F and H, arrows). Scale bar
represents 100 mm.
(I and J) Confocal images of proximal III nerves oriented
withbrainstemto the left andorbit to the right fromE12.5
Kif21a+/+;IslMN:GFP (I) and Kif21aKI/KI;IslMN:GFP (J)
embryos reveal a bulb within the proximal nerve (arrow)
followed by distal thinning (arrowhead) in all mutant and
noWT nerves (n = 20, 20). Scale bar represents 100 mm.
(K–N) Confocal images of WT and mutant III nerves
stained with anti-NF antibody. (K) and (L) correspond
to regions of arrow and arrowhead in (I), while (M) and
(N) correspond to regions of arrow and arrowhead in
(J) (n = 3, 3). Scale bars represent 20 mm.
(O–T) Stitched images of multicolor anterograde
labeled III axons in Kif21a+/+ (O, Q, and S) and
Kif21aKI/KI (P, R, and T) at E12.5. OMNsd (Sd) contra-
lateral neurons are red (Q and R), while both ipsilateral
and contralateral neurons are green (O and P). When
merged (S and T), Sd axons from the contralateral
nucleus appear yellow, while ipsilateral OMNid (Id)
axons remain green. Primarily contralateral yellow
axons (T) terminate within the bulb (arrow in P and R)
and along the nerve, failing to reach the developing
eye (white circle) in Kif21aKI/KI but not Kif21a+/+ em-
bryos (n = 3, 3). Scale bar represents 200 mm.
(U–Z) Confocal images of dorsal view of flat-mounted
midbrain tissue highlight normal nuclear formation and
normal density of the axons of Sd motor neurons as
they cross the midline at E12.5 (U and V), E13.5 (W
and X), and E14.5 (Y and Z) in WT (U, W, and Y) and
Kif21aKI/KI;IslMN:GFP (V, X, and Z) embryos (n = 5, 5 at
each age). Note that (U)–(X) are higher magnification of
(E)–(H). Scale bar represents 200 mm.
(AA–AF) Ventricular view of flat-mounted midbrains
with motor neurons in the OMN nucleus labeled
retrogradely following dye application in the orbit of
one eye of E12.5–E14.5 Kif21a+/+ (AA, AC, and AE) or
Kif21aKI/KI (AB, AD, and AF) embryos (n = 12, 11). In WT
embryos, dye fills the axons of the Sd motor neurons
crossing the midline of Kif21a+/+ embryos. In contrast,
in mutant embryos, fewer Sd axons are retrograde
labeled from the orbit in Kif21aKI/KI embryos, despite
similar density by GFP detection (refer to U–Z). Scale
bar represents 30 mm. Abbreviations: III, OMN nerve;
IV, trochlear nerve; versus, sensory branches of the
trigeminal nerve; Vm, motor branch of the trigeminal
nerve; VI, abducens nerve; VII, facial nerve; IX, glos-
sopharyngeal nerve; XI, accessory nerve; XII, hypo-
glossal nerve; E, eye; Sd, OMNsd; Id, OMNid.
See also Figure S2.
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KIF21A Function in CFEOM1 and Developmentcontralaterally migrating OMN neuron population. Examination
of E12.5–E14.5 embryos (Figures 2U–2Z and also 3T) revealed
that the migration of OMNsd cell bodies across the midline be-
tween E12.5–E14.5 appeared to proceed normally in Kif21aKI/KI
mice. Thus, we attempted to retrograde label these crossing
axons by placing dye in the developing orbit. A smaller subset
of mutant motor neurons crossing the midline was labeled by
retrograde dye compared to WT (Figures 2AA–2AF, S2Q, and
S2R), consistent with the termination of most OMNsd axons
within the proximal nerve and bulb.
The Developing Distal Kif21aKI/KI Oculomotor Nerve
Superior Division Is Hypoplastic while the Inferior
Division Develops Aberrant Branches
Kif21a+/+, Kif21a+IKI, and Kif21aKI/KI mutant fluorescent ocular
nerves, together with surrounding tissue and orbit, were
dissected from E12.5 IslMN:GFP embryos to visualize their
complete trajectories. While the trochlear nerve appeared
normal, the distal OMN and abducens nerves appeared thin (Fig-
ures 3A and 3B), consistent with the loss of OMN and, to a lesser
degree, abducens motor neurons in the mature animals. More-
over, the images confirmed proximal thickening, bulb formation,
and distal thinning of the Kif21aKI/KI OMN nerve and revealed
hypoplasia of its developing distal OMNsd. The thin OMNsd
was confirmed in an E14.5 Kif21a+IKI embryo by two-photon
microscopy and three-dimensional reconstruction (Movies S1Figure 3. Failure of Oculomotor Axon Development Is the Primary Def
(A–J) Confocal images of ocular motor nerves dissected from Kif21a+/+;IslMN:GFP
The III nerve and its branches labeled in red text, IV and VI nerves labeled in yellow
mutant (B) mice; n = 10, 10. Note the proximal bulb (*) and distal thinning of III wi
nerve, and thinning of VI (arrowhead) compared to WT. Scale bars represent 200
mice at E11.5 (C and D), E12.5 (E and F), E13.5 (G and H), and E15.5 (I and J); n =
appear to explore the local environment, but mutants have fewer exploring axons
protrudes from the WT nerve, and the Id exhibits an enlarged distal region with
mutant nerve (F) has thinner Sd and Id, and several aberrant, fasciculated branche
amore substantial Sdwith several fasciculated bundles, while themutant (H) Sd is
(arrow) as well as the normal branch to the IO. At E15.5, WT III (I) appears fully d
branches, presumably to theMR, IR, and IO. In comparison, mutant III (J) Sd is sev
similar to WT, with no visible aberrant branches. Compared to WT, mutant VI w
normal.
(K) Onset of Kif21a expression in EOMs during development. Immunostaining wit
through the eye of E12.5, E13.5, and E14.5 WT mice. Kif21a is detected in the ret
but is absent from green EOMs (arrows) until E14.5, subsequent to its neuronal e
(L) Histological sections of the mouse orbit at E14.5 reveal proper size and posit
(M–R) Fluorescent whole-mount imaging of developing III nerves stained with an
(O and P), and E12.5 (Q and R) from Kif21a+/+;IslMN:GFPWT (M, O, and Q) and Kif2
from E12.5 because of high background at this age. Arrowheads and arrows indic
represent 100 mm.
(S) Quantification of proximal (odd numbered solid bars) and distal (even number
from at least n = 3 Kif21a+/+;IslMN:GFP (blue bars 1–6) and Kif21aKI/KI;IslMN:GFP (g
0.004. p values: 1:2 < 0.001*, 1:3 = 0.032, 1:5 = 0.000*, 1:7 = 0.098, 2:4 < 0.001*, 2:
0.006, 5:6 = 0.148, 5:11 = 0.025, 6:12 < 0.001*, 7:8 = 0.007, 7:9 = 0.541, 7:11 =
11:12 = 0.001*.
(T) Increased apoptosis of III neurons is observed at E12.5 and E14.5 inKif21aKI/KI (
motor neurons crossing the midline (*) in WT and mutant mice, and an increase in
crossing the midline at E14.5.
(U) Quantification of Caspase3+ cells in Kif21a+/+ and Kif21aKI/KI embryos demons
4) at each stage. Caspase3+ neurons in the III nucleus bilaterally of WT versus Kif2
versus 68 ± 3; E14.5, 43 ± 2 versus 76 ± 3; E15.5, 43 ± 1 versus 44 ± 0.5; mean
branch; O, optic nerve and as per Figure 2.
See also Movies S1 and S2.and S2), consistent with its absence in the human CFEOM1
autopsy study (Engle et al., 1997).
Next, OMN nerves were dissected from E11.5–E15.5 embryos
to define the normal and abnormal development of the distal
superior and inferior branches (Figures 3C–3J). Visualizing the
distal aspect of the nerve, we found that WT axons paused
and followed complex trajectories prior to forming branches to
innervate target EOM. This behavior is consistent with devel-
oping axonal populations arriving at ‘‘decision regions’’ to turn
or to enter a target in vivo, as documented in growth cones of
chick spinal motor neurons within the plexus (Tosney and Land-
messer, 1985), retinal ganglion cell at the optic chiasm (Mason
and Erskine, 2000), and cortical neurons within the corpus
callosum (Kalil et al., 2000). In mutants, the developing OMNsd
was markedly thinner than that of WT nerves at all ages, while
the OMNid appeared moderately thinner, with premature fascic-
ulation into transient aberrant branches. At E15.5, the mutant
abducens nerve was thinner while the trochlear appeared similar
to wild-type.
Kif21aKI/KI Oculomotor Nerve Pathology Does Not Arise
from a Primary Defect in EOM Development, Axon
Retraction, or Motor Neuron Cell Death
Next, we asked whether the OMN pathology in Kif21aKI/KI mice,
which begins prior to E12.5, could result from a primary defect in
EOM development. We found, however, that while Kif21aect in CFEOM1
and Kif21aKI/KI;IslMN:GFPmice, with brainstem to the left and eye to the right.
text. (A and B) Lowmagnification of ocular motor nerves from E12.5WT (A) and
th hypoplasia of the distal superior (Sd) and inferior (Id) divisions of the mutant
mm. (C–J) Distal OMN nerves in WT (C, E, G, and I) and mutant (D, F, H, and J)
10, 10 for each age. At E11.5, both WT and mutant nerves reach the orbit and
within the distal decision region (C and D). At E12.5, a small, defasciculated Sd
a subset of axons pursuing convoluted trajectories (E). In contrast, the E12.5
s (arrows) emerge from the Id exploratory region. At E13.5, theWT nerve (G) has
thin or absent, and the Id exploratory region is small and has aberrant branches
eveloped, with Sd branches to the SR and LPS. The Id now sends off several
erely hypoplastic, while the Id is thin but sends off several stereotyped branches
as also hypoplastic compared to WT (arrow head), while mutant IV appeared
h anti-Kif21a antibody (red) and anti-Myo antibody (green) on coronal sections
ina and in rootlets of many developing nerves (including III and VI, arrowheads)
xpression.
ioning of EOMs in Kif21aKI/KI compared to Kif21a+/+ mice.
ti-NF antibody (red) and anti-Tuj1 antibody (green) at E10.5 (M and N), E11.5
1aKI/KI;IslMN:GFPmutant (N, P, and R) embryos. Anti-Tuj1 staining was omitted
ate proximal and distal OMN nerve at points of measurement in (S). Scale bars
ed hatched bars) III nerve diameters in (M)–(R) from left and right OMN nerves
reen bars 7–12) embryos at E10.5–E12.5. Mean ± SEM. *Significant p value <
6 < 0.001*, 2:8 = 0.713, 3:4 = 0.010, 3:5 = 0.195, 3:9 = 0.335, 4:6 = 0.001*, 4:10 =
0.004, 8:10 = 0.056, 8:12 = 0.037, 9:10 < 0.001*, 9:11 = 0.059, 10:12 = 0.990,
right) compared toKif21a+/+ (left) mice. Note a similar proportion of Isl1-positive
Caspase3+ cells in Kif21aKI/KI embryos both within the III nuclei and in neurons
trates increased apoptosis at E12.5–E14.5 in the III but not the IV nuclei; (n = 4,
1aKI/KIwere E11.5, 6 ± 0.5 versus 7 ± 1; E12.5, 8 ± 1 versus 34 ± 3; E13.5, 28 ± 2
± SD. **p < 0.001. Abbreviations: Sd, OMNsd; Id, OMNid; IO, inferior oblique
Neuron 82, 334–349, April 16, 2014 ª2014 Elsevier Inc. 339
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expression in EOMbegan at E14.5 (Figure 3K), several days after
the nerve pathology. We also found the position and size of the
SR and LPS muscles appeared normal at E14.5 (Figure 3L)
and that EOM hypoplasia began after P0, several days after
EOM innervation was reduced (Figures 1L–1Q).
To confirm that the OMN bulb resulted from premature axon
termination rather than axon retraction, we measured proximal
and distal OMN nerve diameters in WT and mutant embryos at
E10.5, E11.5, and E12.5 (Figures 3M–3S). The proximal diameter
of the WT nerve at E10.5 was approximately twice that of its
distal diameter, while by E11.5 there was no significant differ-
ence between them, probably reflecting the growth of additional
axons along the WT nerve between E10.5 and E11.5. Neither
proximal nor distal diameter of the mutant nerve differed signifi-
cantly fromWT at E10.5. In contrast to WT, however, the mutant
proximal diameter increased significantly over time, while the
distal diameter did not, resulting in distal nerve thinning. This is
consistent with a reduction in axon growth down the mutant
nerve compared to WT after E10.5.
We hypothesized that the loss of OMN neurons in adult
Kif21aKI/KI mice was secondary to failure of axon elongation
and examined their relative timing. OMN and trochlear motor
neurons were colabeled with Islet1 and activated Caspase3
(Cas3+) antibodies in both Kif21aKI/KI and Kif21a+/+ littermates
at E11.5–E16.5 (Figures 3T and 3U). Kif21a+/+ motor neurons
underwent a wave of natural apoptotic cell death between
E12.5–E15.5. At E11.5, when growth of Kif21aKI/KIOMNsd axons
had already fallen behind Kif21a+/+, the number of Cas3+-posi-
tive cells in the OMN nucleus was similar to WT. From E12.5–
E15.5, however, the number of Cas3+-positive OMN, but not
trochlear, neurons inKif21aKI/KImice was significantly increased.
Thus, Kif21aKI/KI OMN nerve growth failure precedes motor
neuron apoptosis. Taken together, these findings support a
neurogenic etiology for CFEOM1, with primary failure of axon
elongation to the orbit.
Kif21aKI/KI Bulb Contains Misdirected Axons with
Enlarged Growth Cones and Increased Numbers of
Filopodia
To examine the ultrastructure of the mutant bulb, we examined
E12.5 nerves from two mutant mice in cross-section at levels
within and just proximal and distal to the bulb and compared
to nerves from two WT mice at equivalent proximal and distal
cross-sectional levels (Figures 4A–4E). Compared to the cross-
sectional area of the proximal mutant nerve prior the bulb, the
area within the bulb was increased 3.5- to 4-fold, while the
area distal to the bulb was decreased 3-fold (Figure S3A),
consistent with mutant OMN nerve distal thinning.
For each of the five cross-sections (Figures 4A–4E), we
counted and measured all objects and labeled them as axons
cut in cross-section, axons cut longitudinally or obliquely, central
growth cones, lamellipodia/filopodia, or degenerating axons
(Figures 4F–4I, S3B, and S3C). Proximal and distal sections of
both WT andmutant nerves consisted primarily of axons running
parallel to the nerve trajectory, with a small number of moderate-
sized growth cones and lamellipodia/filopodia (Figures 4F–4I).
WT nerves contained similar numbers of axons, and axon num-340 Neuron 82, 334–349, April 16, 2014 ª2014 Elsevier Inc.ber did not vary greatly between proximal and distal levels. In
contrast, the mutant nerves’ distal sections contained 55%
fewer axons than proximal sections, and the proximal sections
contained 18% fewer axons than WT proximal sections (Figures
4N and S3D). The moderate reduction in mutant nerve proximal
axons probably reflects pathologic cell death in the E12.5
Kif21aKI/KI OMN nucleus (refer to Figures 3T and 3U), while the
much greater reduction in mutant nerve distal axons is consis-
tent with axon termination in the bulb.
To determine whether CFEOM1 mutations visibly alter the
distribution of organelles, we examined proximal nerve sections,
as these included cross-sectional axons of the OMNsd destined
to stall as well as OMNid axons destined to pass through the bulb
(Figure S3B). We found no difference in the average densities of
vesicles, membranes, or mitochondria between mutant and WT
axons (Figures S3E and S3F). These data support absence of a
general disruption of axonal trafficking.
We examined bulb ultrastructure and found it to be highly
disorganized, with many axons running perpendicular to the
cross-sectional plane (Figures 4J–4M). Moreover, there was a
remarkable increase in growth cone size and in number of filopo-
dia and degenerating axons (Figures 4N, 4O, S3D, and S3G).
These findings are again reminiscent of normal decision regions
in which populations of axons change direction. Within such
regions, growth cones cease forward movement, enlarge,
extend multiple filopodia, and develop erratic-appearing trajec-
tories prior to establishing the correct new direction of growth
(Mason and Erskine, 2000). Taken together, our results suggest
a model in which WT OMNsd axons normally reach the distal
nerve, where they pause and explore the environment and then
turn and fasciculate as its superior branch. In contrast, in the
CFEOM1 disease state, our data suggest that these axons stall
within the proximal nerve, where they explore the environment
within the bulb region, fail to form an aberrant OMNsd, and
then degenerate.
TheKif21aKI/KICFEOM1Phenotype Results from aGain-
of-Function Mechanism
All reported CFEOM1 mutations are heterozygous, result in a
single amino acid substitution or deletion in the motor or third
coiled-coil stalk of KIF21A (Figure 1A), and cause indistinguish-
able human phenotypes. These genetic data strongly support
altered KIF21A function underlying CFEOM1. We previously
noted, however, that the level of R954W mutant KIF21A protein
in human CFEOM1 postmortem brain tissue lysates was
reduced (Desai et al., 2012). Thus, we asked whether loss of
KIF21A function caused CFEOM1.
We examined Kif21aKI/KI brain lysates and found, similar to the
human autopsy, that Kif21a protein levels were reduced 35%,
45%, and 60% compared to WT in E13.5, E18.5, and adult
mice, respectively (Figure S4A), while Kif21a mRNA levels did
not differ (Figures S4B and S4C). Thus, Kif21a mutant protein
level appears highest during the embryonic period when
CFEOM1 pathology occurs. To determine whether the reduction
of Kif21a protein in Kif21aKI/KI mice contributed to the CFEOM1
phenotype, we generated Kif21a knockout mice by deleting
much of the motor domain (Figures S4D–S4G). The resulting
homozygous mice completely lacked full-length (FL) Kif21a
Figure 4. Ultrastructural Analysis of Devel-
oping Oculomotor Nerves in Kif21a+/+ and
Kif21aKI/KI Embryos
(A–E) Stitched electron microscopy (EM) images
(4,8003) of E12.5 Kif21a+/+;IslMN:GFP (A and B)
and E12.5 Kif21aKI/KI;IslMN:GFP (C, D, and E) III
nerve cross-sections. (A) and (C) are equivalent
proximal levels, while (B) and (D) are equivalent
distal levels and correspond to cross-sections of
the nerve just proximal and distal to the bulb (E) in
the mutant nerve. Scale bars represent 10 mm.
(F–M) EM images (13,0003) from cross-sections
in (A)–(E). Proximal (F and H) and distal (G and I)
sections of WT (F and G) and mutant (H and I)
nerves consist primarily of axons running parallel
to the nerve trajectory with a few central growth
cones (stars) and lamellipodia/filopodia (asterisk).
Cross-section of mutant bulb (J–M) contain highly
disorganized axons and increased numbers of
longitudinal axons (arrows), enlarged central
growth cones (stars), lamellipodia/filopodia
(asterisks), aggregation of mitochondria, mem-
branes and vesicles (empty arrowheads), and
degenerating axons (filled arrowheads). Scale
bars represent 500 nm.
(N and O) Stacked graphs showing numbers (N)
and average areas (O) of cross-sectional, longitu-
dinal, and degenerating axons of central growth
cones and of lamellipodia/filopodia from two
mutant and two WT III nerves at cross-sectional
levels shown in (A)–(E). The number/value for each
object is provided within or above each fraction.
#1 and #2, WT nerves; #3 and #4, mutant nerves;
p, proximal; d, distal; b, bulb.
See also Figure S3.
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missing the motor domain necessary for motor-microtubule
interaction and anterograde movement; we refer to them as
Kif21a knockout-motor truncation mice (Kif21aKOMT). While the
low level of truncated protein could act as a dominant negative,
it existed at less than 15% of the WT protein level. Therefore, the
mouse pathology should encompass any Kif21a loss-of-function
phenotype. Kif21a+/KOMT mice were viable, appeared phenotyp-
ically normal, and none had the external CFEOM1 phenotype
found in 43% of Kif21a+IKI mice. Although Kif21aKOMT/KOMT
mice died within 24 hr of birth, the developing OMN nerve did
not contain a bulb or distal thinning found in Kif21aKI/KImice (Fig-Neuron 82, 334–3ures 5A–5H), and OMN neuron apoptosis
was equivalent to WT mice (Figures
5I–5K). Thus, loss of FL WT Kif21a does
not cause CFEOM1.
To address whether absolute or rela-
tive levels of mutant Kif21a protein modu-
lates penetrance of CFEOM1 in vivo,
we crossed Kif21a+IKI and Kif21a+/KOMT
mice to generate Kif21aKI/KOMT mice,
which harbored the lowest levels of
Kif21a protein (Figure 5L), of which all
was mutant. Remarkably, Kif21aKI/KOMTmice survived, indicating one mutant copy of Kif21a, present at
lower levels than one WT copy, is sufficient for survival, yet
only 22% of Kif21aKI/KOMT adult mice had an external CFEOM1
phenotype and this phenotype was mild. Overall penetrance of
the external CFEOM1 phenotype was 22% in Kif21aKI/KOMT
compared to 92% in Kif21aKI/KI and 43% in Kif21a+IKI adult
mice and, while Kif21aKOMT/KOMT mice do not survive, no
Kif21aKOMT/KOMT embryo had CFEOM1 OMN nerve pathology
(Figure 5M). These data suggest that the mouse is protected
against CFEOM1 by reduced numbers of Kif21a dimers contain-
ing one or two mutant proteins. Thus, CFEOM1 penetrance cor-
relates with the absolute amount of mutant Kif21a protein and is49, April 16, 2014 ª2014 Elsevier Inc. 341
Figure 5. Loss of FL Kif21a Does Not Cause CFEOM1
(A–H) OMN anterograde dye tracer studies in Kif21a+/+ and Kif21aKOMT/KOMT embryos (n = 10, 9), as shown for Kif21aKI/KI mice in Figure S2O, reveal normal exit,
fasciculation, and trajectory of III axons and absence of a bulb or distal thinning at E12.5 (A–D) and E13.5 (E–H). Scale bars represent 100 mm in (A), (C), (E), and (G)
and 20 mm in (B), (D), (F), and (H).
(I and J) Islet1 and Cas3+ immunohistochemistry of E14.5 WT (I) and Kif21aKOMT/KOMT (J) III nuclei reveal Islet1+ motor neurons crossing the midline and several
Cas3+ apoptotic neurons.
(K) Quantification of the number of Cas3+ cells in (I) and (J) reveal absence of pathological apoptosis in III nuclei of Kif21aKOMT/KOMT compared to Kif21a+/+
embryos at E13.5 (n = 6, 6, 29 ± 2 versus 30 ± 2; mean ± SD; p = 0.206) and E14.5 (n = 6, 6, 48 ± 3 versus 46 ± 2; mean ± SD; p = 0.334).
(L) Representative western blot analysis of Kif21a protein levels in E18.5 brain tissues corresponding to genotypes in allelic series (n = 4). Note lowest levels of
Kif21a protein detected in Kif21aKI/KOMT mice.
(M) Summary of genotypes and phenotypes from allelic analysis of Kif21a mutant mice. Percentages are relative to WT/WT mice. A 23 2 contingency table with
Fisher’s exact test was used to determine differences in penetrance between Kif21aKI/KOMT and Kif21aKI/KI mice (p = 0.0001).
(N and O) E18.5 Kif21a+/+ or Kif21aKI/KI brain lysates were incubated with polymerized microtubules and AMP-PNP or ATP and microtubule cosedimentation
assays performed. Representative western blot (N) and quantification (O) show significantly increased relative levels of Kif21a in microtubule pellet fraction (P2)
for endogenous mutant Kif21a compared to WT Kif21a (n = 3). Mean ± SEM. **p < 0.01, ***p < 0.001, ns, not significant.
(legend continued on next page)
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mechanism.
Kif21a-Microtubule Association Is Regulated by
Interaction of the Motor and Third Coiled-Coil Domains,
and CFEOM1 Motor and Stalk Mutations Disrupt This
Interaction
To explore how CFEOM1 mutations alter Kif21a function, we
conducted in vivo cell fractionation of E18.5 Kif21a+/+ and
Kif21aKI/KI brain tissue lysates and found enhanced association
of mutant Kif21a with the cytoskeleton compared to WT (Figures
S4H and S4I). Next, we cosedimented Kif21a and polymerized
microtubules from E18.5 Kif21a+/+ and Kif21aKI/KI brain tissue
lysates. The relative amount of mutant Kif21a was significantly
higher in the microtubule pellet (P2) fraction and lower in the
soluble (S2) fraction compared to WT Kif21a (Figures 5N and
5O). These data support enhanced microtubule binding of
endogenous mutant Kif21a in vivo.
To determine whether other CFEOM1 mutations and various
Kif21a truncations would also enhance association of Kif21a
with the microtubule cytoskeleton, we generated a series of
Kif21a FL and truncated constructs (Figure 5P) into which we
introduced one of the motor domain substitutions (MT1,
M356T in both human and mouse) and two of the third coiled-
coil domain substitutions (MT2 and MT3, human M947I and
R954W corresponding to mouse M936I and R943W, respec-
tively). We confirmed that both FL WT and mutant Kif21a formed
homodimers, and the amount of dimerized protein did not differ
between them (Figure S5A). We then overexpressed the trunca-
tion and FL mutant constructs in HEK293 cells and cosedi-
mented Kif21a and polymerized microtubules from each cell
lysate. Significantly more WT or MT1 stalk-truncated, as well
as FL MT1, MT2, and MT3, mutant constructs were associated
with the microtubule fraction compared to FLWT Kif21a (Figures
6A and 6B). Moreover, the increased association of the WT and
MT1 truncation was indistinguishable. These changes in micro-
tubule association were also directly visualized following overex-
pression of the constructs in HeLa cells (Figures S5B–S5E).
The indistinguishable CFEOM1 phenotypes in humans (Demer
et al., 2005; Yamada et al., 2003) and the increased Kif21a-
microtubule association resulting from substitutions within either
the KIF21A motor or third coiled-coil domain led us to search for
a single disease mechanism specific to these domains. Several
kinesins have been demonstrated in vitro to autoregulate their
activity by folding within a stalk linker region and stabilizing
the folded conformation through intramolecular interactions
(reviewed in Verhey and Hammond, 2009). Thus, we asked
whether WT Kif21a is similarly autoregulated, and whether
CFEOM1 mutations alter KIF21A autoinhibition. We performed
coimmunoprecipitation and found that the motor domain inter-(P) Names and corresponding schematics of the FL and truncated Kif21a constr
taining mutant amino acid residues corresponding toMT1, MT2, or MT3 have the a
end with the tag designation: ‘‘G-’’ at the start denotes an N-terminal GFP tag, wh
tag, respectively; ‘‘m’’ or ‘‘h’’ prior to the parenthesis denotesmouse or human con
residues contained in the construct and is followed by MT1, MT2, or MT3 if th
constructs have slightly different amino acid numbering.
See also Figure S4.acted only with the third coiled-coil domain (Figures 6C, 6D,
and S5F). To determine whether this interaction regulated
Kif21a function, we performed in vitro single-molecule fluo-
rescence imaging assays using total internal reflection (TIRF)
microscopy. In BRB80 buffer, fewWT FL Kif21a bound to micro-
tubules and moved processively, consistent with Kif21a existing
primarily in an autoinhibited state (Figure 6E; Movie S3). In
contrast, both WT and MT1 mutant Kif21a truncated prior to
the third coiled-coil domain showed a significant increase in
the number of active (land-and-run) landing events (Figures 6F,
6G, and 6K; Movies S4 and S5). Moreover, there was no signifi-
cant difference between the WT and MT1 truncation constructs,
demonstrating that CFEOM1 motor mutations do not directly
alter the ATP enzymatic activity or microtubule-binding motif.
We then testedwhether purifiedWT third coiled-coil domain pro-
tein could block the microtubule-binding activity of the trunca-
tion construct. Indeed, WT-truncated Kif21a active landing
events were dramatically inhibited with the introduction of WT
third coiled-coil domain in trans (Figures 6H and 6K; Movie S6).
Next, we asked whether CFEOM1 mutations alter Kif21a
autoinhibition. We found that the interaction of the motor and
third coiled-coil was attenuated by the introduction of the
MT1-motor or the MT2- or MT3-stalk mutations (Figures 6C,
6D, S5F, and S5G).We repeated the single-molecule experiment
combining either WT truncation with purified MT3 mutant third
coiled-coil protein or MT1 mutant truncation with WT third
coiled-coil protein in trans. As predicted, both combinations
failed to fully block the active landing events of truncated
Kif21a (Figures 6I–6K and S5H; Movies S7 and S8). Moreover,
introduction of the mutant constructs increased the ratio of
active versus inactive (dead motor) landing events compared
to WT (Figure S5I).
Lastly, we asked how CFEOM1 mutations alter FL Kif21a
microtubule association andmotile properties.While an increase
in the frequency of active landing events of mutant Kif21a was
evident in BRB80 buffer, run lengths were too short for accurate
measurement (Figures S5J and S5K). Thus, we used BRB30, a
lower ionic strength buffer that permitted quantification of both
landing and motile properties. In contrast to FL WT Kif21a,
both FL MT1- and MT3-Kif21a had a 10-fold increase in the
frequency of active landing events (Figures 6L–6O; Movie S9),
while also decreasing the percentage of inactive landing events
or dead motors (Figure S5L). We measured velocities and run
lengths of active motors for all three FL constructs and found
no significant differences between them (Figure 6P).
Collectively, these data establish that Kif21a adopts an auto-
inhibited state through the direct and specific interaction of its
motor and third coiled-coil stalk domains and reveal that this
stalk-induced autoinhibition is partially released by CEFOM1
mutations, enhancing the association of Kif21a motors withucts. Kif21a domains are noted above the top left construct. Constructs con-
mino acid substitution represented in red font. Construct code names begin or
ile ‘‘-G,’’ ‘‘-mCh,’’ or ‘‘-M’’ at the end denote a C-terminal GFP, mCherry, or Myc
struct, respectively; the number within the parentheses denotes the amino acid
e construct contains a CFEOM1 amino acid substitution. Mouse and human
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Figure 6. CFEOM1Mutations Disrupt Kif21a Intramolecular Interactions between theMotor and Third Coiled-Coil Domains, Attenuate Auto-
inhibition, and Enhance Kif21a Microtubule Binding without Altering Run Length or Velocity
(A and B) Mouse GFP-fused FLWT, MT1, MT2, or MT3 Kif21a, or stalk-truncatedWT or MT1mutant Kif21a was overexpressed in HEK293 cells, andmicrotubule
cosedimentation assays performed. Representative western blot (A; n = 3) and quantification (B) show significantly increased relative levels in the microtubule
pellet fraction (P2) of the three mutant FL Kif21a and bothWT andMT1 stalk truncations compared to theWT FL Kif21a. Mean ± SEM. *p < 0.05, **p < 0.01, ***p <
0.001, ns, not significant.
(C) Representative western blot (n = 3) shows that overexpressed GFP-fused motor (G-m(1-417)) domain specifically coimmunoprecipitates with Myc-tagged
third coiled-coil (h(891-1300)-M) domain and not with first and second coiled-coil (h(385-890)-M) or WD40 (h(1301-1674)-M) domain from HEK293 cell lysates
using anti-myc antibody, and third coiled-coil domain CFEOM1 mutations (MT2 and MT3) disrupt this coimmunoprecipitation.
(D) Representative western blot (n = 3) shows that introduction of the MT1 mutation into overexpressed GFP-fused motor domain disrupts immunoprecipitation
with WT Myc-tagged third coiled-coil domain from HEK293 cell lysates using anti-myc antibody.
(legend continued on next page)
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Figure 7. Oculomotor Growth Cones in Kif21aKI/KI Explant Cultures Have Increased Growth Cone Size and Number of Filopodia
(A) Representative immunofluorescent images showing Thy1:GFP WT and Kif21aKI/KI OMN explants cultured for 3 days. Scale bars represent 400 mm.
(B) Quantification of axon outgrowth from (A) shows no significant differences in OMN axon outgrowth between WT/WT and KI/KI mice (n = 5, 3). Mean ± SEM.
(C–F) Percentage of growth cones with forward, stationary, or retracted movements (C), forward distance traveled (D), total displacement (E), and percent
collapse (F) quantified from 30 min recordings of IslMN:GFP Kif21aKI/KI and WT OMN explants cultured for 17–20 hr. No significant differences between WT and
Kif21aKI/KI mice were detected (n = 9, 8). Mean ± SEM.
(G) Representative immunofluorescent images of phalloidin-stained WT and Kif21aKI/KIOMN axon growth cones in explants cultured for 18 hr from the IslMN:GFP
mice. Scale bars represent 5 mm.
(H and I) Quantification of (G) reveals a significant increase in growth cone area (H) and number of filopodia per growth cone (I) of Kif21aKI/KI explants compared to
WT (n = 4 explants and 164 growth cones, n = 3 explants and 139 growth cones). Mean ± SEM. *p < 0.05.
See also Figure S6.
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motor’s velocity and run length. Collectively, these data confirm
and expand recently published in vitro data (van der Vaart et al.,
2013). We also provide in vivo evidence of attenuated autoinhibi-
tion by CFEOM1-Kif21a motor and stalk mutations.
Kif21aKI/KI Oculomotor Explant Axons Have Normal
Growth but Enlarged Growth Cones and Increased
Filopodia
Despite wide expression of Kif21a, CFEOM1 pathology is
restricted to OMN axons. Thus, we cultured OMN nuclei from
Thy1:GFP and IslMN:GFP mice and examined the growth of(E–J) Representative kymographs showing the displacement on a microtubule ov
truncation; (G) MT1 mutant truncation; (H) WT truncation plus 50 mM purified WT t
coil domain; (J) MT1 mutant Kif21a truncation plus 50 uM purified WT-3CC. Sca
(K) Quantification of (E)–(J) reveals Kif21a WT {G-m(1-917)} and mutant {G-m(1-9
compared to that of Kif21aWT FL {G-m(1-1573)}. PurifiedWT-3CC inhibits landing
have a reduced inhibitory effect.
(L–N) Representative kymographs showing the displacement on a microtubule ov
mutant FL; and (N) MT1 mutant FL. Scale bars as per (E)–(J).
(O and P) Quantification of mouse WT FL or mutant (MT3 and MT1) FL Kif21a on m
landing frequencies (O) of MT3 and MT1 mutant FL Kif21a compared to WT, but n
and (P), data were acquired from two independent experiments, and from three
mean ± SD, run length: mean ± SEM. *p < 0.05, **p < 0.01, ns, not significant. C
See also Figure S5 and Movies S3, S4, S5, S6, S7, S8, and S9.GFP-positive OMN axons in WT versus Kif21aKI/KI explant
cultures. There were no significant differences in overall growth
characteristics or percent of axons with collapsed growth cones
(Figures 7A–7F).
We next examined the OMN growth cones by immunohisto-
chemistry in fixed explants cultured for 18 hr. We found a
moderate but significant increase in both growth cone area
and number of filopodia per growth cone in Kif21aKI/KI explants
compared to WT (Figures 7G–7I). Kif21a is recruited by Kank1
to the cell cortex in vitro (van der Vaart et al., 2013), and overex-
pressed CFEOM1 mutant KIF21A enhances Kif21a-Kank1 inter-
action in vitro (Kakinuma and Kiyama, 2009). Thus, we compareder 5 min in BRB80 motility buffer of mouse GFP-fused Kif21a: (E) WT FL; (F) WT
hird coiled-coil domain; (I) WT truncation plus 50 mM purified MT3 third coiled-
le bars: x axis represents 5 mm, y axis represents 1 min.
17MT1)} truncations have significantly higher microtubule landing frequencies
frequencies ofWT Kif21a truncation, while CFEOM1mutations (MT1 andMT3)
er 5 min in BB30 motility buffer of mouse GFP-fused Kif21a: (L) WT FL; (M) MT3
icrotubules for 10 min in BRB30 motility buffer reveals a significant increase in
o significant changes in velocity or run length (P). For each construct in (K), (O),
time-lapsed images for each experiment. Frequency: mean ± SEM, velocity:
onstructs are per Figure 5P.
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body of both Kif21a and Kank1 but found no differences in either
ratio between WT and Kif21aKI/KI explants (Figures S6A–S6D).
These data support mild attenuation but not complete ablation
of Kif21a autoinhibition. Moreover, while enlarged growth cones
with increased numbers of filopodia in vitro probably share a
common pathogenesis with bulb formation by mutant OMN
axons in vivo, the in vitro phenotype is much milder, supporting
an important environmental contribution to the development of
CFEOM.
CFEOM3-causing TUBB3 missense mutations stabilize yeast
microtubules and alter Kif21a-microtubule interactions (Tisch-
field et al., 2010). Thus, we asked whether we could detect a
difference in microtubule plus-end behavior by tracking EB3
protein following overexpression of WT versus mutant Kif21a in
COS7 cells. Although WT Kif21a decreased microtubule poly-
merization rate and microtubule dynamics slightly but signifi-
cantly compared to the control, consistent with recently reported
data (van der Vaart et al., 2013), we did not detect a significant
difference between the behavior of WT and CFEOM1 mutant
Kif21a (Figures S6E–S6H).
Endogenous Kif21a and MAP1B Interact, and Map1b–/–
Mice Have CFEOM
To identify additional Kif21a-interacting partners that could play
a role in the pathogenesis of CFEOM1, we immunoprecipitated
E18.5 WT brain lysates with IgG and with three different anti-
Kif21a antibodies, each of which recognized a distinct region
of the Kif21a protein, and then performed mass spectrometry
(data not shown). One consensus candidate we identified was
the microtubule-associated protein 1b (Map1b) heavy chain, a
major cytoskeletal protein essential for axondevelopment in vivo.
There are intriguing similarities between loss of Map1b function
and our Kif21aKI/KI data. Loss of Map1b impairs growth cone
turning in vitro and axon guidance in vivo (Bouquet et al., 2004;
Mack et al., 2000; Meixner et al., 2000). CulturedMap1b/ neu-
rons have increased growth cone area and number of filopodia
and altered microtubule dynamics with longer pauses and fewer
catastrophes (Gonzalez-Billault et al., 2002; Tortosa et al., 2013;
Tymanskyj et al., 2012). Finally, the eyes of Map1b/ mouse
models are reported to appear ptotic and retracted (Meixner
et al., 2000; Takei et al., 1997; Edelmann et al., 1996).
To explore a potential role of Map1b in CFEOM1, we
confirmed the interaction of Map1b with WT Kif21a in E18.5
brain tissue lysates and then determined that endogenous
WT and CFEOM1 mutant Kif21a interacted equally well with
Map1b by coimmunoprecipitation (Figure 8A). A GST pull-
down assay demonstrated that Kif21a interacted with Map1b
through its third coiled-coil stalk and WD40 domains (Fig-
ure 8B). Furthermore, we performed a microtubule cosedi-
mentation assay with E18.5 WT and Map1b/ brain tissue
lysates. Loss of Map1b did not generally disrupt microtubule
polymerization, nor did it alter the level of WT Kif21a or KHC
bound to microtubules (Figure 8C), suggesting that Map1b
does not regulate the autoinhibition of Kif21a-microtubule
interactions.
We next examined the external eye phenotype of Map1b/
mice and found that it closely resembled the Kif21aKI CFEOM1346 Neuron 82, 334–349, April 16, 2014 ª2014 Elsevier Inc.phenotype and was also 90% penetrant (Figures 8D and 8E).
The trajectory of the OMN nerve appeared normal, similar to
Kif21aKI mice (Figures 8F and 8G). We then generated
Map1b+/;IslMN:GFP and Map1b/;IslMN:GFP mice to examine
the developing OMN nerve in finer detail. Compared to WT (Fig-
ures 8H and 8I), all Map1b+/ OMN nerves appeared normal
(Figures 8J and 8K), while 90% of Map1b/ nerves had mild
proximal thickening in the absence of a bulb, distal thinning,
hypoplasia of the OMNsd, and a smaller OMNid (Figures 8L
and 8M). Moreover, 30% of Map1b/ distal OMN nerves
had aberrant, long, fasciculated branches that emerged from
the OMNid exploratory region (Figure 8M). In contrast,
while 50% of Kif21a+/KI distal OMN nerves had only mild
proximal thickening and distal thinning compared to WT (Fig-
ures 8N and 8O), the other 50% had proximal bulbs and sig-
nificant distal nerve hypoplasia and branching defects (Figures
8P and 8Q), as described for Kif21aKI/KI embryos (Figures 3B
and 3F).
Finally, we asked whether the interaction of Map1b and
Kif21a was physiologically relevant by examining the OMN
nerve of double heterozygous mice. Further analysis revealed
that penetrance of the bulb phenotype (found in no Map1b+/
or Map1b/ mice and in 50% of Kif21a+IKI mice) rose to
90% in Map1b+/; Kif21a+IKI ;IslMN:GFP mice, and their distal
nerve pathology resembled the more severely affected
Kif21a+IKI and Kif21aKI/KI mice. The penetrance of abducens
nerve hypoplasia also rose from 50% in Kif21a+/KI to 90%
in double heterozygous Kif21a+/KI:Map1b+/ mice, while the
trochlear nerve appeared normal in all crosses. Taken together,
the Map1b/ OMN nerve innervation defects closely pheno-
copy the CFEOM1 mutant Kif21aKI nerve, both Map1b/ and
Kif21aKI mice develop CFEOM, and analysis of double hetero-
zygous mice supports a genetic interaction between Map1b
and Kif21a in CFEOM.
DISCUSSION
Since first described in the late 1800s (Heuck, 1879), the etiology
of CFEOM1 has been unknown, and whether it was primarily
neuropathic or myogenic remained unclear. By introducing the
most common CFEOM1 KIF21A missense mutation into mice,
we recapitulate the human phenotype in both heterozygous
and homozygous states. Analysis of Kif21aKI mice reveals that
the CFEOM1 phenotypes of ptosis and restricted upgaze reflect
failure of LPS and SR innervation secondary to developmental
stalling of their growing OMNsd axons, while variably restricted
and aberrant horizontal movements probably result from more
subtle errors in innervation of the OMNid muscles. These studies
establish a neurogenic etiology for CFEOM1.
Kinesin motor proteins are important for many aspects of
neuronal development, and it is presumed that their activities
need to be tightly regulated. Our data confirm that Kif21a
can adopt a preferred autoinhibited state that requires the
interaction of the lateral motor and third coiled-coil stalk domains
and an active state in which this interaction has been released
and Kif21a binds to the microtubule. CFEOM1 mutations atten-
uate Kif21a autoinhibition by disrupting this interaction,
enhancing Kif21a association with microtubules without altering
Figure 8. Endogenous Kif21a and MAP1B
Interact, Map1b–/– Mice Have CFEOM, and
the Penetrance of the Oculomotor Pheno-
type Is Greater in Map1b+/–;Kif21a+/KI
Compared to Single Heterozygous Embryos
(A) E18.5 WT and Kif21aKI/KI brain lysates immu-
noprecipitated with control IgG, anti-Kif21a anti-
body, or anti-Map1b antibody and subjected to
western blotting using the antibodies indicated.
WT and mutant Kif21a interact equally with Map1b
in both directions but do not interact with Map2.
(B) Western blot of GST pull-down of E18.5 WT
brain lysates by purified GST-motor, GST-Kif21a-
third coiled-coil and -WD40 domains. Kif21a in-
teracts withMap1b through its third coiled-coil and
WD40 domains.
(C) E18.5 Map1b+/+ or Map1b/ brain lysates
were incubated with AMP-PNP or ATP and
microtubule cosedimentation assays were per-
formed. Western blot shows similar relative
levels of Kif21a and KHC in the microtubule pellet
fraction (P2).
(D and E) Map1b+/+ mice have normal eyes (D),
while Map1b/ mice have globe retraction and
ptosis (E).
(F and G) Fluorescent whole-mount imaging of
E11.5 III nerve (arrow) from Map1b+/+ (F) and
Map1b/ (G) mice stained with anti-NF antibody
(red). The nerves have similar trajectories (n = 4, 4).
(H–S) Confocal images of III, IV, and VI nerves (left
column) and higher magnification of the distal III
nerve (right column) from E12.5 IslMN:GFP
embryos, oriented and labeled as described in
Figures 3A–3J, with VI nerve (arrowhead), aberrant
III nerve branches (arrows), and OMN bulb (*). WT
(H and I),Map1b+/ (J and K),Map1b/ (L and M),
Kif21a+/KI (N–Q), and double heterozygous
Kif21a+/KI:Map1b+/ (R and S) mice; n = 10, 10 for
each genotype. Scale bars represent 200 mm in (H),
(J), (L), (N), (P), and (R) and 100 mm in (I), (K), (M), (O),
(Q), and (S). Abbreviations as per Figure 2.
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mechanism for both motor and stalk mutations to account for
the indistinguishable human phenotypes.
While perturbed kinesin autoinhibition in worm, fungus, and fly
in vivo are reported to cause loss-of-function phenotypes
(Imanishi et al., 2006; Moua et al., 2011; Seiler et al., 2000), we
find that loss of KIF21A function does not cause CFEOM1, and
attenuated Kif21a autoinhibition resulting from CFEOM1
mutations does not result in the Kif21a null phenotype. Together,
our data support gain-of-function mutations underlying
CFEOM1 and suggest that both homozygous and heterozygous
mutant dimers can disrupt Kif21a autoinhibition. Notably, while
most human mutations in other kinesins cause partial or com-
plete loss of function, mutations in KIF22 and KIF5A highlight
specific residues that could prove important for autoregulation
(Boyden et al., 2011; Crimella et al., 2012). Thus, pathological
alterations of autoinhibition may extend beyond KIF21A andrepresent a more generalized mechanism underlying disorders
of kinesin function.
Despite the broad expression of Kif21a (Desai et al., 2012)
and its attenuated autoinhibition by CFEOM1 mutations both
in vivo and in vitro, it is intriguing that these mutations selectively
target ocular motor neuron development. These vulnerable
OMN axons appear to form a pathological decision region
defined by stalled axons with enlarged growth cones and turning
defects, similar to the behavior of WT OMN axons when they
enter a distal decision region near the orbit, as well for other
axon populations within decision regions for turning (Mason
and Erskine, 2000). We have found that Kif21a interacts with
the Map1b heavy chain through its third coiled-coil and WD40
domains and that Kif21aKI/KI and Map1b/ embryos have
similar OMN nerve pathology that results in CFEOM and is
accentuated in the double heterozygous state. Similar to our
findings in Kif21aKI/KI neurons, others have shown aberrantNeuron 82, 334–349, April 16, 2014 ª2014 Elsevier Inc. 347
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KIF21A Function in CFEOM1 and Developmentturning behavior and enlarged growth cones in Map1b/ neu-
rons (Bouquet et al., 2004; Gonzalez-Billault et al., 2002; Mack
et al., 2000; Tortosa et al., 2013). Moreover, both Map1b and
Kif21a can regulate microtubule dynamics in neuronal growth
cones (Tortosa et al., 2013; Tymanskyj et al., 2012; van der Vaart
et al., 2013). Thus, the interaction between these two proteins is
likely to play a critical role in the pathogenesis of CFEOM1.
Combined with our previous reports of CFEOM3 arising from
mutations in either TUBB3 or TUBB2B (Cederquist et al., 2012;
Tischfield et al., 2010), these data highlight a selective vulnera-
bility of the developing OMN nerve to perturbations of the axon
cytoskeleton.
EXPERIMENTAL PROCEDURES
Detailed procedures are described in the Supplemental Experimental
Procedures.
Transgenic Mice
Detailed description of targeting strategy and generation of Kif21aKI/KI and
Kif21aKOMT/KOMT can be found in the Supplemental Experimental Procedures.
129S1 Kif21aKI and 129S1 Map1bKO mice were crossed to B6/129S1
IslMN:GFP (Lewcock et al., 2007) or Thy1:GFP reporter mice (Jackson Labora-
tory) and studied following aminimum of four backcrosses to 129S1. All animal
work was performed in compliance with Boston Children’s Hospital IACUC
Protocols.
Embryo Dissection, Immunohistochemistry, and Ultrastructural
Analysis
Briefly, for immunohistochemistry, embryos and adult mice were dissected
and fixed in 4% PFA. After blocking with serum, whole embryos or dissected
tissues were sequentially incubated with primary and secondary antibodies.
For ultrastructural analysis, embryos were fixed in 2% paraformaldehyde,
2.5% glutaraldehyde, 0.02% CaCl2, and 2% tannic acid in 0.1 M cacodylate
buffer at room temperature, and a tissue block containing the OMN nerve
was prepared for electron microscopy.
Anterograde and Retrograde Labeling
Anterograde and retrograde labeling of E14.5 and P0 ocular cranial nerves
and EOMs were performed by placing NeuroVue Maroon (red) or Jade (green)
dye (MTTI)-soaked filter strips at specific axial levels of the brainstem or orbit.
After dye diffusion, brainstems or orbits were observed for successful
dye placement and completely labeled samples were prepared for confocal
microscopy. Consecutive scans and stacks of images through the nerve
and/or each nucleus were collected using a laser-scanning confocal
microscope.
Microtubule Cosedimentation Assay
Microtubule cosedimentation assay was performed as described previously
(Tischfield et al., 2010) with modifications detailed in the Supplemental Exper-
imental Procedures. Clarified lysates in BRB80 buffer of E18.5 WT and mutant
brains or HEK293 cells overexpressing WT or mutant Kif21a constructs were
incubated with polymerized microtubules, palitaxol, and AMP-PNP or ATP at
37C, centrifuged at 55,000 rpm at 25C, and then subjected to SDS-PAGE
and western blot.
Coimmunoprecipitation, Protein Purification, and GST Pull-Down
Clarified lysates in lysate buffer (50 mM TrisHCl, 150 mM NaCl, 1 mM EDTA,
1% NP40 [pH 6.8]) of E18.5 WT and mutant brains or HEK293 cells overex-
pressing WT or mutant Kif21a constructs were incubated with antibody and
protein-G agarose beads with gentle rotation at 4C overnight. After washing
with lysate buffer, denatured elutions were subjected to SDS-PAGE and west-
ern blot. For GST pull-down, GST-fused proteins were expressed and purified
from E. Coli BL21 cells with glutathione sepharose beads. Clarified lysates (as
described above) were incubated with protein-bounded beads at 4C for 4 hr.348 Neuron 82, 334–349, April 16, 2014 ª2014 Elsevier Inc.The final denatured elutions were subjected to SDS-PAGE and western blot.
For in vitro single-molecule motility assays described below, thrombin was
used to cleave off the GST tag.
In Vitro Single-Molecule Motility Assays
Single-molecule assays of GFP-fused WT or mutant Kif21a constructs were
performed in motility chambers as previously described (Qiu et al., 2012).
Coverslips were sequentially coated with 1 mg/ml biotin-BSA and 0.5 mg/ml
streptavidin to immobilize Taxol-stabilized Cy5 microtubules. Clarified cell
lysates containing equal amounts of protein were diluted in motility buffer
and added to the chamber. Images were recorded every 2 s for 5 or 10 min
using an Olympus IX-81 TIRF microscope.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and nine movies and can be found with this article online at
http://dx.doi.org/10.1016/j.neuron.2014.02.038.
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